| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $39.8M | +3.0% |
| SG&A Expense | $15.7M | +26.8% |
| Operating Income | -$59.6M | -38.5% |
| Pre-tax Income | -$58.4M | -36.3% |
| Net Income | -$58.4M | -36.3% |
| EPS (Basic) | -$1.38 | -35.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | -93.3% |
| Short-term Investments | $56.9M | — |
| Current Assets | $71.8M | -39.6% |
| Total Assets | $74.5M | -37.9% |
| Current Liabilities | $6.1M | -9.4% |
| Total Liabilities | $8.1M | +12.2% |
| Stockholders' Equity | $66.3M | -41.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.5M | -57.9% |
| Capital Expenditures | $272K | — |
| Investing Cash Flow | -$57.1M | -181.6% |
| Financing Cash Flow | $3.1M | -38.9% |
| Free Cash Flow | -$52.7M | — |